Arteriocyte, Inc.

Arteriocyte’s focus is the development of stem cell-based therapies to treat ischemia in patients suffering from coronary artery disease, peripheral vascular disease, stroke, and renal ischemia. The Company was founded in January of 2004 and is based upon more than 4 years of NIH sponsored research utilizing stem cells to stimulate angiogenesis (new vessel growth). Arteriocyte’s development program is focused on creating cellular therapies that will trigger new blood vessel growth to relieve ischemia in patients who suffer from insufficient blood flow to their organs and tissues. Arteriocyte’s Scientists have identified and conducted extensive research on vascular delivery of defined combinations of stem cells to ischemic tissue, and while their research has utilized stem cells from a variety of sources, Arteriocyte’s ultimate goal is to develop umbilical cord blood - a rich source of stem cells - as the basis for the company’s cellular medicines.

Contact Details: 11000 Cedar Avenue Cleveland Ohio 44106 United States of America Tel: (216) 658-3970 Fax: (216) 229-7323 Email: info@arteriocyte.com WWW: www.arteriocyte.com/

Loading...

Press Releases on Arteriocyte, Inc.:
Stem Cell Product Commercialization Focus of Summit	7th January, 2009	RRY Publications	PHILADELPHIA, Jan. 7 /PRNewswire/ -- RRY Publications announced that the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors, will focus on
Preliminary Lineup Set for 4th Annual Stem Cell Summit	12th August, 2008	RRY Publications	PHILADELPHIA, Aug. 12 /PRNewswire/ -- RRY Publications today announced the preliminary lineup of presenters for the 4th Annual Stem Cell Summit, the premier gathering of stem cell company

BioNews Results for Arteriocyte, Inc.:
PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Me	Guru Focus:  Nov 22 2009 3:56PM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Cogent Inc, AMERICAN PUBLIC EDUCATION, INC, Whitne	Guru Focus:  Nov 22 2009 5:13PM Matching: inc
N.J. index reaches a yearly high	Asbury Park Press:  Nov 22 2009 12:49PM Matching: inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.	Individual.com:  Nov 21 2009 6:41AM Matching: inc
Stocks That Stand Out For Nov. 20th, 2009 Are ARTS, RFMD, CLDS, ACTC	Pharmacy Choice:  Nov 21 2009 1:27PM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Arteriocyte, Inc. news.

Arteriocyte, Inc. Clinical Trials:
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 456 times since April 2007, the link to the organisation's website has been followed 61 times

Recent Search Terms used to find this page: ARTERIOCYTE INC | Arteriocyte | arteriocyte medical investor profile | arteriocyte | arteriocyte | Arteriocyte careers | arteriocyte careers | Arteriocyte | arteriocyte inc careers | arteriocyte | .

Search for more companies in Cleveland

Search for more companies in Ohio

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Arteriocyte, Inc.